Roxana Jimenez Garcia
Medical · San Antonio, TXNPI 1629217104
Payments from drug & device makers
Across 343 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AstraZeneca$1K
- Novo Nordisk$919
- Astellas Pharma US Inc$628
- Johnson & Johnson$265
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$229
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,19697%
- Education$1703%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 60 | $1,085 |
| AstraZeneca | 45 | $1,057 |
| Novo Nordisk | 57 | $919 |
| Astellas Pharma US Inc | 25 | $628 |
| Johnson & Johnson | 13 | $265 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $229 |
| Otsuka America Pharmaceutical, Inc. | 19 | $221 |
| GSK | 12 | $198 |
| Bayer | 14 | $183 |
| Abbott | 9 | $171 |
| Lundbeck LLC | 7 | $165 |
| Merck | 6 | $146 |
| Sanofi-aventis U.S. LLC | 6 | $121 |
| Nestle Healthcare Nutrition Inc. | 6 | $107 |
| Pfizer | 7 | $104 |
| Shield Therapeutics Inc | 6 | $103 |
| Exact Sciences | 5 | $96 |
| Sanofi Pasteur Inc. | 4 | $85 |
| Eisai Inc. | 3 | $60 |
| Dexcom, Inc. | 3 | $59 |
| Amgen | 3 | $53 |
| Novartis | 3 | $52 |
| Atland Pharmaceuticals, LLC | 1 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| AbbVie | 3 | $40 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Phadia US Inc. | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,366 in reported general payments places this provider in the 85th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 95 | $114,429 |
| MounjaroTirzepatide | 91 | $113,930 |
| JanuviaSitagliptin Phosphate | 75 | $86,540 |
| TradjentaLinagliptin | 51 | $58,461 |
| XareltoRivaroxaban | 47 | $45,955 |
| EliquisApixaban | 31 | $35,106 |
| JardianceEmpagliflozin | 22 | $23,830 |
| TrulicityDulaglutide | 13 | $21,229 |
| ProliaDenosumab | 12 | $20,913 |
| FarxigaDapagliflozin Propanediol | 25 | $20,192 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $13,712 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $12,107 |
| MyrbetriqMirabegron | 17 | $8,868 |
| Rosuvastatin Calcium | 543 | $5,256 |
| VascepaIcosapent Ethyl | 12 | $5,012 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $1,085 | $135,159104 claims |
| Novo NordiskOzempic | $919 | $114,42995 claims |
| MerckJanuvia | $146 | $86,54075 claims |
| Boehringer IngelheimTradjenta, Jardiance | $12 | $82,29073 claims |
| Johnson & JohnsonXarelto | $265 | $45,95547 claims |
| PfizerEliquis | $104 | $35,10631 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,057 | $32,29939 claims |
| AmgenProlia | $53 | $20,91312 claims |
| Astellas Pharma US IncMyrbetriq | $628 | $8,86817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,490 medical providers in Texas.
Other medical in San Antonio
- Jose de la CerdaSan Antonio$1.1M
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- John KodoskySan Antonio$58K
- Amanda MillerSan Antonio$27K
- Felipe GalvanSan Antonio$26K
- Ledyenska BallesterosSan Antonio$22K
- Daniella ArellanoSan Antonio$15K
- Robert SchonhoffSan Antonio$14K
- Tanya GainesSan Antonio$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.